CoChat
Sign Up
Cited by 103Parkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration MechanismsImmune Response and Inflammation

The DOI matches its Crossref record; 204 of the 204 references it cites were found in a registry or an index.

TLR2 and TLR4 in Parkinson’s disease pathogenesis: the environment takes a toll on the gut

Open access
Gorecki, Anastazja M., Anyaegbu, Chidozie C., Anderton, Ryan S.·2021·Translational Neurodegeneration
DOI 10.1186/s40035-021-00271-0PMC PMC8609261
Open this paper in CoChat — free accountOpen PDF

Abstract

Parkinson’s disease (PD) is an incurable, devastating disorder that is characterized by pathological protein aggregation and neurodegeneration in the substantia nigra. In recent years, growing evidence has implicated the gut environment and the gut-brain axis in the pathogenesis and progression of PD, especially in a subset of people who exhibit prodromal gastrointestinal dysfunction. Specifically, perturbations of gut homeostasis are hypothesized to contribute to α-synuclein aggregation in enteric neurons, which may spread to the brain over decades and eventually result in the characteristic central nervous system manifestations of PD, including neurodegeneration and motor impairments. However, the mechanisms linking gut disturbances and α-synuclein aggregation are still unclear. A plethora of research indicates that toll-like receptors (TLRs), especially TLR2 and TLR4, are critical mediators of gut homeostasis. Alongside their established role in innate immunity throughout the body, studies are increasingly demonstrating that TLR2 and TLR4 signalling shapes the development and function of the gut and the enteric nervous system. Notably, TLR2 and TLR4 are dysregulated in patients with PD, and may thus be central to early gut dysfunction in PD. To better understand the putative contribution of intestinal TLR2 and TLR4 dysfunction to early α-synuclein aggregation and PD, we critically discuss the role of TLR2 and TLR4 in normal gut function as well as evidence for altered TLR2 and TLR4 signalling in PD, by reviewing clinical, animal model and in vitro research. Growing evidence on the immunological aetiology of α-synuclein aggregation is also discussed, with a focus on the interactions of α-synuclein with TLR2 and TLR4. We propose a conceptual model of PD pathogenesis in which microbial dysbiosis alters the permeability of the intestinal barrier as well as TLR2 and TLR4 signalling, ultimately leading to a positive feedback loop of chronic gut dysfunction promoting α-synuclein aggregation in enteric and vagal neurons. In turn, α-synuclein aggregates may then migrate to the brain via peripheral nerves, such as the vagal nerve, to contribute to neuroinflammation and neurodegeneration typically associated with PD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s40035-021-00271-0

Cites

204 of 204 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Representative schematic of TLR2 and TLR4 distribution in the gut. The Toll-like receptors 2 and 4 (TLR2 and TLR4) are expressed by many different cell populations throughout the gastrointestinal barrier, where they are activated by microbial metabolites and endogenous molecules. TLR2 and TLR4 are expressed by intestinal epithelial cells (IECs) and enteroendocrine cells (EECs) in the epithelial barrier, macrophages, dendritic cells in the submucosa, and smooth muscle cells in the muscular layer of the gut and throughout the enteric nervous system (subepithelial and myenteric, neurons and glia) [37, 81, 125, 126]. In addition to a role in innate immunity, TLR2 and TLR4 in the gut can regulate homeostasis and permeability, and influence motility through their effect on the enteric nervous system [3]. Figure created with Biorender.com
Fig. 1 Representative schematic of TLR2 and TLR4 distribution in the gut. The Toll-like receptors 2 and 4 (TLR2 and TLR4) are expressed by many different cell populations throughout the gastrointestinal barrier, where they are activated by microbial metabolites and endogenous molecules. TLR2 and TLR4 are expressed by intestinal epithelial cells (IECs) and enteroendocrine cells (EECs) in the epithelial barrier, macrophages, dendritic cells in the submucosa, and smooth muscle cells in the muscular layer of the gut and throughout the enteric nervous system (subepithelial and myenteric, neurons and glia) [37, 81, 125, 126]. In addition to a role in innate immunity, TLR2 and TLR4 in the gut can regulate homeostasis and permeability, and influence motility through their effect on the enteric nervous system [3]. Figure created with Biorender.comCC BY · PubMed Central
Fig. 2 Representative schematic of TLR-driven gut dysfunction which may contribute to PD. Microbial dysbiosis and pro-inflammatory gut responses can result in a complex positive feedback loop of gut leakiness and inflammation. For example, microbial dysbiosis (1) contributes to the signalling of epithelial toll-like receptors (TLRs) (2), which can result in a leaky gut (3) and further TLR signalling (4) with subsequent cytokine secretion (5) and immune cell activation (6), leading to TLR-associated dysbiosis [3, 4]. Such gut inflammation can alter the enteric nervous system signalling and result in altered motility (7) [135]. It is hypothesised that α-synuclein is secreted by enteric neurons in response to infection to function as an immune-signalling molecule [159], and α-synuclein can directly activate and also change the expression of TLR2 and TLR4, causing further inflammatory responses [57, 58]. Over time, chronic TLR signalling, gut inflammation and sustained α-synuclein secretion may contribute to the formation of insoluble α-synuclein aggregates in the gut, especially if combined with other molecular deficits (e.g., lysosomal dysfunction). This may cause gut dysfunction (e.g. constipation), which is increasingly recognised as a ‘prodromal PD’ phase [20, 36]. Studies demonstrate that insoluble α-synuclein aggregates can spread from the gut to the brain via peripheral nerves (e.g., vagus nerve), where they cause Lewy body pathology in the CNS, neuroinflammation and neurodegeneration, resulting in the characteristic motor impairments of PD [27–30]. Figure created with Biorender.com
Fig. 2 Representative schematic of TLR-driven gut dysfunction which may contribute to PD. Microbial dysbiosis and pro-inflammatory gut responses can result in a complex positive feedback loop of gut leakiness and inflammation. For example, microbial dysbiosis (1) contributes to the signalling of epithelial toll-like receptors (TLRs) (2), which can result in a leaky gut (3) and further TLR signalling (4) with subsequent cytokine secretion (5) and immune cell activation (6), leading to TLR-associated dysbiosis [3, 4]. Such gut inflammation can alter the enteric nervous system signalling and result in altered motility (7) [135]. It is hypothesised that α-synuclein is secreted by enteric neurons in response to infection to function as an immune-signalling molecule [159], and α-synuclein can directly activate and also change the expression of TLR2 and TLR4, causing further inflammatory responses [57, 58]. Over time, chronic TLR signalling, gut inflammation and sustained α-synuclein secretion may contribute to the formation of insoluble α-synuclein aggregates in the gut, especially if combined with other molecular deficits (e.g., lysosomal dysfunction). This may cause gut dysfunction (e.g. constipation), which is increasingly recognised as a ‘prodromal PD’ phase [20, 36]. Studies demonstrate that insoluble α-synuclein aggregates can spread from the gut to the brain via peripheral nerves (e.g., vagus nerve), where they cause Lewy body pathology in the CNS, neuroinflammation and neurodegeneration, resulting in the characteristic motor impairments of PD [27–30]. Figure created with Biorender.comCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 204 references

Research works printed but not linked: 1

  1. Zhang F, Gao XD, Wu WW, Gao Y, Zhang YW, Wang SP. Polymorphisms in toll-like receptors 2, 4 and 5 are associated with Legionella pneumophila infection. Infection. 2013;41(5):941–8. · DOI

Cited by

Sorted by citations

See all 103

Related

Metadata

Authors
Gorecki, A. M., Anyaegbu, C. C., & Anderton, R. S.
Affiliations
  • The University of Western Australia (AU)
  • Curtin University (AU)
  • The University of Notre Dame Australia (AU)
Corresponding author
Gorecki, Anastazja M.
ORCID
Venue
Translational Neurodegeneration
Publisher
Springer Science and Business Media LLC
Published
2021-11-17
Volume
10
Issue
1
Pages
47-47
ISSN
2047-9158 (ISSN-L)
DOI
10.1186/s40035-021-00271-0
PMC
PMC8609261
OpenAlex
W3215959508
Cited by
103
References
204
Citations by year
2026: 13 · 2025: 26 · 2024: 28 · 2023: 28 · 2022: 7 · 2021: 1
FWCI
2.05
Type
journal article
Language
en
Open access
Licence
Locations
  • Translational Neurodegeneration (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • UWA Profiles and Research Repository (UWA) (submittedVersion, cc-by)
  • ResearchOnline@ND (The University of Notre Dame) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • australian government (Australian Government Research Training Program Scholarship)
  • parkinson’s western australia (Zrinski Grant)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
Keywords
Parkinson's disease, TLR2, TLR4, Toll-like receptors, gut-brain axis, alpha-synuclein aggregation, gut dysbiosis, intestinal permeability, enteric nervous system, vagus nerve, neuroinflammation, neurodegeneration, innate immunity
MeSH terms
Animals, Humans, Parkinson Disease, Substantia Nigra, Toll-Like Receptor 2, Toll-Like Receptor 4, Dysbiosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review